The stock has witnessed selling pressure off late owing to the company’s name associated with Zenith Multi Trading DMCC (Zenith).
Posts in category Business Standard
Genesys Int. bags Rs 155 cr contract from BMC (14-03-2024)
Genesys International Corporation has secured a groundbreaking deal with the Brihanmumbai Municipal Corporation (BMC), marking a significant validation of the Genesys New India Map stack . The contract, valued at Rs. 155 crore marks a significant milestone in advanced mapping technology being used for multiple use cases.
KPI Green Energy Ltd leads losers in ‘A’ group (14-03-2024)
Prestige Estates Projects Ltd, Sterling & Wilson Renewable Energy Ltd, Greenpanel Industries Ltd and Archean Chemical Industries Ltd are among the other losers in the BSE’s ‘A’ group today, 14 March 2024.
Davangere Sugar Company Ltd leads losers in ‘B’ group (14-03-2024)
Thinkink Picturez Ltd, Rajnish Wellness Ltd, Relicab Cable Manufacturing Ltd and India Pesticides Ltd are among the other losers in the BSE’s ‘B’ group today, 14 March 2024.
Nifty above 22,100 level; pharma shares rises (14-03-2024)
At 13:30 IST, the barometer index, the S&P BSE Sensex was up 300.26 points or 0.42% to 73,069.72. The Nifty 50 index added 124.10 points or 0.56% to 22,121.80.
NSE SME Shree Karni Fabcom makes strong listing (14-03-2024)
Shares of Shree Karni Fabcom were quoting at Rs 273 on the NSE, a premium of 20.26% compared with the issue price of Rs 227.
TCS partners with Denmark’s telecom service provider – Nuuday (14-03-2024)
To help migrate Nuuday’s IT infrastructure to innovative cloud architecture
Volumes spurt at Sterling & Wilson Renewable Energy Ltd counter (14-03-2024)
Sterling & Wilson Renewable Energy Ltd registered volume of 78.38 lakh shares by 14:14 IST on NSE, a 13.68 fold spurt over two-week average daily volume of 5.73 lakh shares
GMDC jumps on appointing Anupma K. Iyer as CFO (14-03-2024)
Gujarat Mineral Development Corporation (GMDC) rallied 6.26% to Rs 344.35 after the company’s board has appointed Anupma K. Iyer as a chief financial officer (CFO) and key managerial personnel (KMP) of the company with effect from 11 March 2024.
Zydus receives USFDA tentative approval for Edaravone Injection (14-03-2024)
Edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig’s disease). The drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara (India).